Reported Jan 31, 2018 · Terminated
DOXOrubicin Hydrochloride Liposome Injection, 20 mg/10 ml (2 mg/mL), 10 mL Single Use Vial, Distributed by: Sun…
Sun Pharmaceutical Industries, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Sun Pharmaceutical Industries, Inc. · 270 Prospect Plains Rd · Cranbury, NJ · 08512-3605
Is this the product you have?
DOXOrubicin Hydrochloride Liposome Injection20 mg/10 ml (2 mg/mL)10 mL Single Use Vial
- Distributed bySun Pharmaceutical Industries , Inc. Cranbury, NJ 08512
- Manufactured bySun Pharmaceutical Ind. Ltd. Halol-Baroda Highway. Halol-389 350, Gujarat, India. NDC 47335-049-40
- Lot codes and dates
- Lot # JKS0403A Exp 02/2019
- Amount recalled
- 393 vials
Where it was sold
- Nationwide
Why it was recalled
Lack Of Assurance Of Sterility
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Sun Pharmaceutical Industries, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.